Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD

By sjmartinez • March 14, 2023

Fortis S, Quibrera PM, Comellas AP, Bhatt SP, Tashkin DP, Hoffman EA, Criner GJ, Han MK, Barr RG, Arjomandi M, Dransfield MB, Peters SP, Dolezal BA, Kim V, Putcha N, Rennard SI, Paine R 3rd, Kanner RE, Curtis JL, Bowler RP, Martinez FJ, Hansel NN, Krishnan JA, Woodruff PG, Barjaktarevic IZ, Couper D, Anderson WH, Cooper CB; Subpopulations and Intermediate Outcome Measures in COPD Study Investigators. Bronchodilator Responsiveness in Tobacco-Exposed People With or Without COPD. Chest. 2023 Mar;163(3):502-514. doi: 10.1016/j.chest.2022.11.009. Epub 2022 Nov 15. PMID: 36395858; PMCID: PMC9993341.

Tags: bronchodilator, bronchodilator response, bronchodilator responsiveness, bronchodilator reversibility, COPD, Publications, Pulmonary, Critical Care & Sleep Medicine

The Inoculum Effect and Staphylococcus aureus Infective Endocarditis-Time to Reconsider Treatment

Cosgrove SE, Miller LG. The Inoculum Effect and Staphylococcus aureus Infective Endocarditis-Time to Reconsider Treatment? JAMA Netw Open. 2024 Dec 2;7(12):e2451300. doi: 10.1001/jamanetworkopen.2024.51300. PMID: 39705037.

Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with

Fansiwala K, Sauk JS. Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with IBD. Dig Dis Sci. 2024 Dec 20.[...]

Pharmacoequity measurement framework: A tool to reduce health disparities

Patel PM, Essien UR, Happe L. Pharmacoequity measurement framework: A tool to reduce health disparities. J Manag Care Spec Pharm. 2024 Dec 20:1-11. doi: 10.18553/jmcp.2025.24298.[...]